A trial evaluating the efficacy of cell therapy based on autologous platelet-rich plasma (PRP) for the treatment of Achilles and Patellar tendinopathies

Completed

• Conditions: Achilles tendinopathy, patellar tendinopathy; Musculoskeletal Diseases; Achilles tendinitis

• Registration Number: ISRCTN85334402
• Lead Sponsor: niversity Hospital Complex of Vaud (Centre Hospitalier Universitaire Vaudois [CHUV]) (Switzerland)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-11-11
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

1. History (> 6 weeks) of exercise-associated pain along the proximal insertion of the patellar tendon or the Achilles tendon
2. Being at least 18 and no more than 60 years old, either sex
3. Radiologic confirmation of the tendinopathy (MRI or ultrasound)
4. Patient who has signed an informed consent

Exclusion Criteria

1. Absence of informed consent/participation in some other clinical trial
2. Presence of inflammatory?rheumatoid or systemic conditions
3. Presence or history of complications of important lower limb injuries
4. Presence of acute affections of the lower limb (i.e., infection, tendon rupture)
5. Patients requiring non-steroidal anti-inflammatory drug (NSAID) treatment for other type of affections
6. Patients undergoing medical treatment that could inhibit tendinopathies (i.e., fluoroquinolones)

Study & Design

• Study Type: Interventional
• Study Design: Not specified